Ultrasound ablation technology for the treatment of uterine fibroids has been used for more than ten years from clinical research to clinical promotion and application. At present, the technology is becoming more and more mature, and the number of cases treated by ultrasound ablation in China and abroad has exceeded 10,000 each year, gradually becoming a conservative treatment method for uterine fibroids popular among patients. Its main features are: 1, no incision, no bleeding, no puncture, non-invasive non-invasive treatment of uterine fibroids, preservation of the uterus, effective relief of fibroid-related symptoms (heavy menstruation, frequent urination, etc.). 2.One-time treatment, outpatient treatment, no hospitalization, no anesthesia, and more than 2 hours of observation after the end of treatment can leave the hospital. 3.It is suitable for a wide range of symptomatic leiomyomas, including submucosal leiomyoma, interstitial leiomyoma and subplasma leiomyoma, large leiomyoma with a diameter of more than 10 centimeters, multiple leiomyomas, etc. 4.High ablation efficiency, good ablation efficacy, one-time treatment, the average treatment time is more than 1 hour, the average ablation rate of myoma volume is more than 80%, the symptom relief rate is more than 95%, the recurrence rate of myoma is lower than the traditional myoma removal. 5.It can be effectively used for the treatment of fibroids with fertility requirements, and can prepare for pregnancy and normal delivery after treatment.